(LEAD) N. Korea attempted to steal COVID-19 vaccine, treatment technology: NIS
(ATTN: ADDS more details throughout, photo)
SEOUL, Feb. 16 (Yonhap) -- North Korea has attempted to hack into South Korean drug manufacturers' computer systems to obtain information related to coronavirus vaccines and treatment, the state intelligence agency told lawmakers Tuesday.
At a closed-door parliamentary session, the National Intelligence Service (NIS) reported the average daily number of cyberattacks in South Korea has increased 32 percent year-on-year to about 1.58 million cases, most of which were unsuccessful, Rep. Ha Tae-keung of the main opposition People Power Party told reporters after the session.
The NIS also said that North Korea has enhanced its crackdown on anti-socialist acts, upping the punishment for distributing video materials from South Korea to the death penalty, according to lawmakers.
Anyone caught watching South Korean videos is punishable by a jail term of up to 15 years, the NIS said.
"To put it simply, it's punishment for the 'Korean Wave,'" Ha said.
On the public absence of leader Kim Jong-un's wife, Ri Sol-ju, the NIS said that no unusual signs or intelligence have been collected.

National Intelligence Service Director Park Jie-won speaks during a session of the National Assembly's Intelligence Committee on Feb. 16, 2021. (Yonhap)
(END)
-
Injured Wolves forward Hwang Hee-chan to undergo treatment in S. Korea
-
Ex-gov't employee summarily indicted for alleged attempt to sell Jungkook's lost hat
-
BTS fails to win Grammy for 3rd consecutive year
-
S. Korea opens metaverse platform for Korean-language learning
-
Pirates' Choi Ji-man says 'deeply hurt' to be dropped from WBC team
-
Five years after its full nuke armament claim, N. Korea's threat becomes real, further complicated
-
(News Focus) S. Korea grapples with calls for nuclear armament
-
Talk of 'normalizing' GSOMIA raises hope, skepticism around Seoul-Tokyo ties
-
S. Korea, U.S., Japan close ranks amid growing N.K. threats
-
N. Korea says month-old virus crisis under control, but skepticism lingers